Chang David D Insider Trades

Insider Trading History

Track insider trading activity for Chang David D. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Allogene Therapeutics
Allogene Therapeutics ALLO
President And CEO
Holding Value $10.5M 5,150,599 shares
Last Trade
Mar 16, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$118k 47,763 shares
$2.47
$2.04
Allogene Therapeutics
Allogene Therapeutics ALLO
President And CEO
Holding Value $10.6M 5,185,862 shares
Last Trade
Feb 02, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$171k 95,269 shares
$1.80
$2.04
Allogene Therapeutics
Allogene Therapeutics ALLO
President And CEO
Holding Value $2.83M 1,387,931 shares
Last Trade
Feb 02, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$3.33M 1,780,517 shares
$1.87
$2.04
Allogene Therapeutics
Allogene Therapeutics ALLO
President And CEO
Holding Value $10.8M 5,276,569 shares
Last Trade
Mar 14, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$91.5k 46,668 shares
$1.96
$2.04
Allogene Therapeutics
Allogene Therapeutics ALLO
President And CEO
Holding Value $10.8M 5,317,237 shares
Last Trade
Feb 03, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$77.3k 46,003 shares
$1.68
$2.04
Allogene Therapeutics
Allogene Therapeutics ALLO
President And CEO
Holding Value $10.9M 5,363,240 shares
Last Trade
Jan 24, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$3.79M 1,952,130 shares
$1.94
$2.04
Allogene Therapeutics
Allogene Therapeutics ALLO
President And CEO
Holding Value $9.81M 4,810,106 shares
Last Trade
May 16, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1M 344,828 shares
$2.90
$2.04
Allogene Therapeutics
Allogene Therapeutics ALLO
President And CEO
Holding Value $9.11M 4,465,278 shares
Last Trade
Mar 14, 2024 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$231k 53,393 shares
$4.33
$2.04
Allogene Therapeutics
Allogene Therapeutics ALLO
President And CEO
Holding Value $9.21M 4,513,203 shares
Last Trade
Jan 25, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$3.6M 1,123,535 shares
$3.20
$2.04
Allogene Therapeutics
Allogene Therapeutics ALLO
President And CEO
Holding Value $8.56M 4,193,911 shares
Last Trade
Mar 22, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$7.52M 1,492,200 shares
$5.04
$2.04
Allogene Therapeutics
Allogene Therapeutics ALLO
President And CEO
Holding Value $4.63M 2,269,447 shares
Last Trade
Mar 14, 2023 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$124k 22,340 shares
$5.56
$2.04
Allogene Therapeutics
Allogene Therapeutics ALLO
Director, President And CEO
Holding Value $4.48M 2,195,512 shares
Last Trade
Mar 23, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$21.3M 2,195,512 shares
$9.69
$2.04
Allogene Therapeutics
Allogene Therapeutics ALLO
Director, President And CEO
Holding Value $4.67M 2,289,652 shares
Last Trade
Mar 15, 2022 Sale (Open Market)Shares sold on the open market or in a private sale.
$181k 23,648 shares
$7.65
$2.04
Allogene Therapeutics
Allogene Therapeutics ALLO
President And CEO
Holding Value $1.1M 541,190 shares
Last Trade
May 24, 2021 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$690k 27,410 shares
$25.18
$2.04
Allogene Therapeutics
Allogene Therapeutics ALLO
President And CEO
Holding Value $4.72M 2,312,279 shares
Last Trade
May 24, 2021 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$690k 27,410 shares
$25.18
$2.04
Allogene Therapeutics
Allogene Therapeutics ALLO
President And CEO
Holding Value $4.66M 2,284,869 shares
Last Trade
Mar 26, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$12.8M 379,288 shares
$33.78
$2.04
Allogene Therapeutics
Allogene Therapeutics ALLO
President And CEO
Holding Value $4.5M 2,204,417 shares
Last Trade
Mar 15, 2021 Sale (Open Market)Shares sold on the open market or in a private sale.
$791k 20,513 shares
$38.57
$2.04
Allogene Therapeutics
Allogene Therapeutics ALLO
President And CEO
Holding Value $1.75M 856,044 shares
Last Trade
Aug 31, 2020 Purchase (Gift)Shares transferred as a gift rather than bought or sold for cash.
$7.34M 205,778 shares
$35.65
$2.04
Allogene Therapeutics
Allogene Therapeutics ALLO
Director, President And CEO
Holding Value $4.54M 2,224,101 shares
Last Trade
Apr 24, 2020 Purchase (Other)Another type of insider transaction reported on SEC Form 4.
$1.09M 36,770 shares
$29.60
$2.04
Allogene Therapeutics
Allogene Therapeutics ALLO
President And CEO
Holding Value $1.33M 650,266 shares
Last Trade
Mar 18, 2020 Purchase (Gift)Shares transferred as a gift rather than bought or sold for cash.
$15.6M 856,044 shares
$18.22
$2.04

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up